fda warning glp-1 october 2025 Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly FDA approves first generic GLP-1

Evidence-based approacheslike therapy, lifestyle adjustments, and, when appropriate, medications prescribed after a professional evaluationare safer and more effective for lasting relief

This information should be interpreted with a qualified healthcare provider as one data point within a comprehensive clinical picture

This technology works, but it demands strict conditions: the tablet must be taken on an empty stomach with no more than four ounces of water, followed by a 30-minute fast before eating, drinking, or taking other oral medications

I am prediabetic

Congratulations to our wonderful partners Pure Encapsulations and Codeage on this outstanding recognition